Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation
Ulf W Tunn,1 Damian Gruca,2 Peter Bacher3 1Urological Department, Prostate Center, Offenbach, Germany; 2AbbVie Deutschland GmbH and Co, KG, Ludwigshafen, Germany; 3AbbVie, North Chicago, IL, USA Abstract: For nearly three decades, gonadotropin-releasing hormone (GnRH) agonists, particularly leupror...
Saved in:
| Main Authors: | Tunn UW, Gruca D, Bacher P |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2013
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ba306e3cef4144209d7f8a881f32d087 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
by: Rajni Sethi, et al.
Published: (2009) -
Evaluation of prostaglandin F2a, estradiol benzoate and deslorelin acetate protocol for oestrus induction in bitches
by: Rodas-Ruiz,J, et al.
Published: (2015) -
Análogo de GnRH disminuye la secreción de hormona folículo estimulante (FSH) en ovejas prepúberes
by: Recabarren,S E, et al.
Published: (2006) -
The use of GnRH analogs in preserving ovarian function during chemotherapy
by: Omar M. Odeh, et al.
Published: (2021) -
Protocolo largo con análogos de GnRH versus protocolo corto con antagonistas: ¿existen diferencias en cuanto a los resultados de los ciclos de FIV-ICSI?
by: Blasco G,Laura, et al.
Published: (2011)